Literature DB >> 26833704

A low-cost, user-friendly electroencephalographic recording system for the assessment of hepatic encephalopathy.

Sami Schiff1, Mariella Casa1, Valeria Di Caro1, Daniele Aprile1, Giuseppe Spinelli1, Michele De Rui1, Paolo Angeli1, Piero Amodio1, Sara Montagnese1.   

Abstract

UNLABELLED: Electroencephalography (EEG) is useful to objectively diagnose/grade hepatic encephalopathy (HE) across its spectrum of severity. However, it requires expensive equipment, and hepatogastroenterologists are generally unfamiliar with its acquisition/interpretation. Recent technological advances have led to the development of low-cost, user-friendly EEG systems, allowing EEG acquisition also in settings with limited neurophysiological experience. The aim of this study was to assess the relationship between EEG parameters obtained from a standard-EEG system and from a commercial, low-cost wireless headset (light-EEG) in patients with cirrhosis and varying degrees of HE. Seventy-two patients (58 males, 61 ± 9 years) underwent clinical evaluation, the Psychometric Hepatic Encephalopathy Score (PHES), and EEG recording with both systems. Automated EEG parameters were calculated on two derivations. Strong correlations were observed between automated parameters obtained from the two EEG systems. Bland and Altman analysis indicated that the two systems provided comparable automated parameters, and agreement between classifications (normal versus abnormal EEG) based on standard-EEG and light-EEG was good (0.6 < κ < 0.8). Automated parameters such as the mean dominant frequency obtained from the light-EEG correlated significantly with the Model for End-Stage Liver Disease score (r = -0.39, P < 0.05), fasting venous ammonia levels (r = -0.41, P < 0.01), and PHES (r = -0.49, P < 0.001). Finally, significant differences in light-EEG parameters were observed in patients with varying degrees of HE.
CONCLUSION: Reliable EEG parameters for HE diagnosing/grading can be obtained from a cheap, commercial, wireless headset; this may lead to more widespread use of this patient-independent tool both in routine liver practice and in the research setting. (
© 2016 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2016        PMID: 26833704     DOI: 10.1002/hep.28477

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

Review 1.  Outcomes in Clinical Trials Evaluating Interventions for the Prevention and Treatment of Hepatic Encephalopathy.

Authors:  Lise L Gluud; Rebecca Jeyaraj; Marsha Y Morgan
Journal:  J Clin Exp Hepatol       Date:  2019-02-15

Review 2.  Hepatic encephalopathy.

Authors:  Dieter Häussinger; Radha K Dhiman; Vicente Felipo; Boris Görg; Rajiv Jalan; Gerald Kircheis; Manuela Merli; Sara Montagnese; Manuel Romero-Gomez; Alfons Schnitzler; Simon D Taylor-Robinson; Hendrik Vilstrup
Journal:  Nat Rev Dis Primers       Date:  2022-06-23       Impact factor: 65.038

3.  Comparison of Medical and Consumer Wireless EEG Systems for Use in Clinical Trials.

Authors:  Elena Ratti; Shani Waninger; Chris Berka; Giulio Ruffini; Ajay Verma
Journal:  Front Hum Neurosci       Date:  2017-08-03       Impact factor: 3.169

4.  Adventures in Developing an App for Covert Hepatic Encephalopathy.

Authors:  Jasmohan S Bajaj
Journal:  Clin Transl Gastroenterol       Date:  2017-04-06       Impact factor: 4.488

5.  Predictors of opioid efficacy in patients with chronic pain: A prospective multicenter observational cohort study.

Authors:  Kasper Grosen; Anne E Olesen; Mikkel Gram; Torsten Jonsson; Michael Kamp-Jensen; Trine Andresen; Christian Nielsen; Gorazd Pozlep; Mogens Pfeiffer-Jensen; Bart Morlion; Asbjørn M Drewes
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

Review 6.  Picking Your Brains: Where and How Neuroscience Tools Can Enhance Marketing Research.

Authors:  Letizia Alvino; Luigi Pavone; Abhishta Abhishta; Henry Robben
Journal:  Front Neurosci       Date:  2020-12-03       Impact factor: 4.677

Review 7.  Recent advances in hepatic encephalopathy.

Authors:  Victoria Liere; Gurkarminder Sandhu; Sharon DeMorrow
Journal:  F1000Res       Date:  2017-09-04

8.  Connecting occipital alpha band peak frequency, visual temporal resolution, and occipital GABA levels in healthy participants and hepatic encephalopathy patients.

Authors:  Thomas J Baumgarten; Julia Neugebauer; Georg Oeltzschner; Nur-Deniz Füllenbach; Gerald Kircheis; Dieter Häussinger; Joachim Lange; Hans-Jörg Wittsack; Markus Butz; Alfons Schnitzler
Journal:  Neuroimage Clin       Date:  2018-08-09       Impact factor: 4.881

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.